Longitudinal Study of Gene Expression in the Human Placenta During First-trimester and Full-term Pregnancy at the Single Cell Level
Condition(s) studied
Investigational drug(s) / intervention(s)
Non applicable: Placental transcriptomic analysis
Study summary
The single nucleus RNA-seq approach allows the placental transcriptome to be analyzed from nuclei, thus preserving the integrity of placental syncytium. This approach is feasible on small fragments of villi and offers for the first time the possibility to consider the characterization of gene expression within the structural unit of the human placenta during pregnancy (at the 1st trimester and childbirth)
Eligibility
Primary outcome measure(s)
- Analysis of the cellular transcriptomic trajectory of the human placenta — Day 0
Sequencing data will be analysed at the Institut Cochin, cell trajectories will be modelled and intracellular communications will be inferred - Analysis of the cellular transcriptomic trajectory of the human placenta — At childbirth
Sequencing data will be analysed at the Institut Cochin, cell trajectories will be modelled and intracellular communications will be inferred
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Maternité Port-Royal, Cochin hospital | Paris | IDF | Recruiting |
More Assistance Publique - Hôpitaux de Paris trials in France
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06427408 on ClinicalTrials.gov ↗ ← All trials in France